66th ASH Annual Meeting: A First-Line Treatment Option for Adults with Symptomatic Anemia Due To Lower-Risk MDS

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member

denotes an abstract that is clinically relevant.

denotes that this is a recommended PHD Trainee Session.

denotes that this is a ticketed session.

A First-Line Treatment Option for Adults with Symptomatic Anemia Due To Lower-Risk MDS

Sponsor: Bristol Myers Squibb

Product Theaters

Diseases, Myeloid Malignancies

Room 5B (San Diego Convention Center)

Speaker:

John Edwards, MD, Bristol Myers Squibb

Disclosures:

No relevant conflicts of interest to declare.

For in-person participants only

See more of: Product Theaters